Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pascal Biosciences Inc (PAS.VN)

Pascal Biosciences Inc (PAS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 984
  • Shares Outstanding, K 65,595
  • Annual Sales, $ 0 K
  • Annual Income, $ -480 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $0.00 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.015 unch
on 12/05/22
0.020 -25.00%
on 11/25/22
-0.005 (-25.00%)
since 11/04/22
3-Month
0.015 unch
on 12/05/22
0.025 -40.00%
on 10/19/22
-0.005 (-25.00%)
since 08/29/22
52-Week
0.015 unch
on 12/05/22
0.100 -85.00%
on 03/09/22
-0.065 (-81.25%)
since 12/02/21

Most Recent Stories

More News
Rob Gietl Joins Pascal Biosciences as New Chief Executive Officer

VANCOUVER, BC / ACCESSWIRE / September 7, 2021 / Pascal Biosciences Inc. ("Pascal") (TSXV:PAS) (OTC:PSCBF) (FSE: 6PB-FF), announced today the appointment of Rob Gietl as Chief Executive Officer and President,...

PAS.VN : 0.015 (-25.00%)
PSCBF : 0.1010 (-8.18%)
Hardy Forzley Joins Pascal Biosciences as Chief Financial Officer

VANCOUVER, BC / ACCESSWIRE / June 16, 2021 / Pascal Biosciences Inc. ("Pascal") (TSXV:PAS) (OTC PINK:PSCBF) (FSE:6PB), announced today the appointment of Hardy Forzley as Chief Financial Officer. Mr. Forzley...

PAS.VN : 0.015 (-25.00%)
PSCBF : 0.1010 (-8.18%)
Pascal Biosciences Awarded NIH Grant For Leukemia Program

VANCOUVER, BC / ACCESSWIRE / June 8, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:PSCBF), has been awarded a grant of US$343,750 from the National Cancer Institute of...

PAS.VN : 0.015 (-25.00%)
PSCBF : 0.1010 (-8.18%)
Pascal Biosciences Announces New OTC Markets Trading Symbol PSCBF

VANCOUVER, BC / ACCESSWIRE / June 1, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:PSCBF, previously BIMUF), has today received a new Over The Counter (OTC) trading symbol...

PAS.VN : 0.015 (-25.00%)
Pascal Biosciences Announces Management Changes

VANCOUVER, BC / ACCESSWIRE / March 22, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19...

BIMUF : 0.0936 (+33.71%)
PAS.VN : 0.015 (-25.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pascal Biosciences Inc is engaged in the research and development of products for the treatment of cancers, and improvement of the immune system. The company has one operating segment, biotechnology research and development with lab and computer equipment in the United States of America.

See More

Key Turning Points

3rd Resistance Point 0.015
2nd Resistance Point 0.015
1st Resistance Point 0.015
Last Price 0.015
1st Support Level 0.015
2nd Support Level 0.015
3rd Support Level 0.015

See More

52-Week High 0.100
Fibonacci 61.8% 0.068
Fibonacci 50% 0.058
Fibonacci 38.2% 0.047
Last Price 0.015
52-Week Low 0.015

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar